Strata Critical Medical, Inc.
SRTA
$5.03
-$0.06-1.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 254.34M | 251.49M | 248.69M | 241.81M | 238.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 254.34M | 251.49M | 248.69M | 241.81M | 238.38M |
| Cost of Revenue | 192.20M | 190.73M | 189.77M | 186.47M | 187.30M |
| Gross Profit | 62.14M | 60.76M | 58.92M | 55.34M | 51.08M |
| SG&A Expenses | 81.88M | 87.63M | 88.22M | 89.66M | 89.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 277.35M | 281.69M | 281.18M | 279.57M | 280.04M |
| Operating Income | -23.01M | -30.20M | -32.49M | -37.75M | -41.66M |
| Income Before Tax | -19.20M | -26.75M | -27.56M | -52.63M | -50.14M |
| Income Tax Expenses | -219.00K | -188.00K | -255.00K | -1.17M | -926.00K |
| Earnings from Continuing Operations | -18.98 | -26.57 | -27.31 | -51.46 | -49.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.98M | -26.57M | -27.31M | -51.46M | -49.21M |
| EBIT | -23.01M | -30.20M | -32.49M | -37.75M | -41.66M |
| EBITDA | -16.72M | -24.14M | -26.52M | -31.51M | -34.86M |
| EPS Basic | -0.24 | -0.34 | -0.35 | -0.68 | -0.65 |
| Normalized Basic EPS | -0.14 | -0.20 | -0.21 | -0.24 | -0.22 |
| EPS Diluted | -0.25 | -0.35 | -0.36 | -0.69 | -0.66 |
| Normalized Diluted EPS | -0.14 | -0.20 | -0.21 | -0.24 | -0.22 |
| Average Basic Shares Outstanding | 317.78M | 314.08M | 309.99M | 306.22M | 302.31M |
| Average Diluted Shares Outstanding | 317.78M | 314.08M | 309.99M | 306.22M | 309.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |